name:-0.097641944885254
name:-0.12447285652161
name:-0.030154943466187
Bavarian Nordic A/S Patent Filings

Bavarian Nordic A/S

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bavarian Nordic A/S.The latest application filed is for "combination therapy for treating cancer with an antibody and intravenous administration of a recombinant mva".

Company Profile
46.161.130
  • Bavarian Nordic A/S - Hellerup DK
  • Bavarian Nordic A/S - Kvistgaard MD DK
  • BAVARIAN NORDIC A/S - MARTINSRIED DE
  • BAVARIAN NORDIC A/S; - Kvistgaard DK
  • BAVARIAN NORDIC A/S -
  • Bavarian Nordic A/S - Kvisgaard DK
  • BAVARIAN NORDIC A/S - KVISTGARD DK
  • Bavarian Nordic A/S - Kvistgaaard DK
  • Bavarian Nordic A/S - Copenhagen DK
  • Bavarian Nordic A/S - Copenhagen S DK
  • BAVARIAN NORDIC A/S - VED AMAGERBANEN COPENHAGEN S DK
  • Bavarian Nordic A/S - Glostrup DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Combination Therapy for Treating Cancer With an Antibody and Intravenous Administration of a Recombinant MVA
App 20220249636 - HOCHREIN; Hubertus ;   et al.
2022-08-11
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens
Grant 11,338,030 - Volkmann , et al. May 24, 2
2022-05-24
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection
App 20220088170 - VOLKMANN; Ariane ;   et al.
2022-03-24
Poxvirus Vectors Encoding HIV Antigens, and Methods of Use Thereof
App 20220088172 - Wegmann; Frank ;   et al.
2022-03-24
Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody
Grant 11,273,211 - Hochrein , et al. March 15, 2
2022-03-15
Poxvirus vectors encoding HIV antigens, and methods of use thereof
Grant 11,229,693 - Wegmann , et al. January 25, 2
2022-01-25
Stable recombinant MVA vectors comprising modified RSV genes with reduced intramolecular recombinatorial activity
Grant 11,225,673 - Steigerwald January 18, 2
2022-01-18
Therapy for Treating Cancer with an Intratumoral or Intravenous Administration of a Recombinant MVA Encoding 4-1BBL (CD137L) and/or CD40L
App 20220000997 - Lauterbach; Henning ;   et al.
2022-01-06
Recombinant Modified Vaccinia Virus Ankara (MVA) Foot and Mouth Disease Virus (FMDV) Vaccine
App 20210393766 - Steigerwald; Robin ;   et al.
2021-12-23
MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen
Grant 11,173,204 - Callendret , et al. November 16, 2
2021-11-16
Methods and compositions for inducing protective immunity against filovirus infection
Grant 11,173,201 - Volkmann , et al. November 16, 2
2021-11-16
Compositions and Methods for Enhancing the Stability of Transgenes in Poxviruses
App 20210338788 - Kalla; Markus ;   et al.
2021-11-04
Methods and Compositions for Enhancing Vaccine Immune Responses
App 20210299236 - Lauterbach; Henning ;   et al.
2021-09-30
Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)
App 20210268104 - BODEN; Daniel ;   et al.
2021-09-02
Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine
Grant 11,103,570 - Steigerwald , et al. August 31, 2
2021-08-31
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor
App 20210205429 - Foy; Susan ;   et al.
2021-07-08
Recombinant Modified Vaccinia Virus Ankara (MVA) Equine Encephalitis Virus Vaccine
App 20210205439 - Steigerwald; Robin ;   et al.
2021-07-08
Stable virus-containing composition
Grant 11,052,147 - Sediq , et al. July 6, 2
2021-07-06
Compositions and methods for enhancing the stability of transgenes in poxviruses
Grant 11,052,139 - Kalla , et al. July 6, 2
2021-07-06
Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine
App 20210196814 - Cheminay; Cedric ;   et al.
2021-07-01
Storage Improved Poxvirus Compositions
App 20210187100 - Kjaer; Katrine ;   et al.
2021-06-24
PR13.5 promoter for robust T-cell and antibody responses
Grant 11,028,130 - Steigerwald , et al. June 8, 2
2021-06-08
Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
Grant 11,020,476 - Boden , et al. June 1, 2
2021-06-01
Methods and compositions for enhancing vaccine immune responses
Grant 10,973,892 - Lauterbach , et al. April 13, 2
2021-04-13
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
Grant 10,946,089 - Cheminay , et al. March 16, 2
2021-03-16
Methods and compositions for inducing protective immunity against a marburg virus infection
Grant 10,925,956 - Callendret , et al. February 23, 2
2021-02-23
Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine
Grant 10,881,725 - Steigerwald , et al. January 5, 2
2021-01-05
Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors
App 20200325477 - Hausmann; Jurgen ;   et al.
2020-10-15
Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Antibody
App 20200306352 - Hochrein; Hubertus ;   et al.
2020-10-01
Recombinant Modified Vaccinia Virus Ankara (MVA) Filovirus Vaccine
App 20200268872 - Volkmann; Ariane ;   et al.
2020-08-27
Stable Virus-containing Composition
App 20200197512A1 -
2020-06-25
Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine
App 20200171142 - Cheminay; Cedric ;   et al.
2020-06-04
Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus
Grant 10,653,766 - Cheminay , et al.
2020-05-19
Poxvirus Vectors Encoding Hiv Antigens, And Methods Of Use Thereof
App 20200138938A1 -
2020-05-07
Mva-bn And Ad26.zebov Or Ad26.filo Prime-boost Regimen
App 20200101153 - CALLENDRET; Benoit Christophe Stephan ;   et al.
2020-04-02
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use
Grant 10,576,141 - Volkmann , et al.
2020-03-03
Compositions and Methods for Enhancing the Stability of Transgenes in Poxviruses
App 20200061174 - Kalla; Markus ;   et al.
2020-02-27
Methods and compositions for inducing protective immunity against filovirus infection
Grant 10,561,721 - Volkmann , et al. Feb
2020-02-18
Methods and compositions for enhancing immune responses
Grant 10,561,722 - Volkmann , et al. Feb
2020-02-18
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection
App 20200038500 - VOLKMANN; Ariane ;   et al.
2020-02-06
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
Grant 10,532,094 - Cheminay , et al. Ja
2020-01-14
Therapeutic HPV vaccine combinations
Grant 10,517,944 - Bunnik , et al. Dec
2019-12-31
Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellin
Grant 10,512,684 - Lauterbach , et al. Dec
2019-12-24
Methods And Compositions For Inducing Protective Immunity Against A Marburg Virus Infection
App 20190224301 - CALLENDRET; Benoit Christophe Stephan ;   et al.
2019-07-25
Methods And Compositions For Inducing An Immune Response Against Hepatitis B Virus (hbv)
App 20190184011 - BODEN; Daniel ;   et al.
2019-06-20
Therapeutic Hpv Vaccine Combinations
App 20190142933 - BUNNIK; Evelien M. ;   et al.
2019-05-16
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine
App 20190117764 - Cheminay; Cedric ;   et al.
2019-04-25
Vector Comprising Multiple Homologous Nucleotide Sequences
App 20190055582 - Steigerwald; Robin
2019-02-21
Recombinant Modified Vaccinia Virus Ankara (mva) Equine Encephalitis Virus Vaccine
App 20190038739 - Steigerwald; Robin ;   et al.
2019-02-07
Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RSV) vaccine
Grant 10,124,058 - Cheminay , et al. November 13, 2
2018-11-13
Poxviral vectors for low antibody response after a first priming immunization
Grant 10,111,946 - Steigerwald , et al. October 30, 2
2018-10-30
Method for harvesting expression products
Grant 10,087,423 - Wehnes , et al. October 2, 2
2018-10-02
Vector comprising multiple homologous nucleotide sequences
Grant 10,072,274 - Steigerwald September 11, 2
2018-09-11
Promoters For Enhancing Expression In Poxviruses
App 20180216134 - Li; Zengji ;   et al.
2018-08-02
Recombinant Modified Vaccinia Virus Ankara (mva) Foot And Mouth Disease Virus (fmdv) Vaccine
App 20180185466 - Steigerwald; Robin ;   et al.
2018-07-05
Pr13.5 Promoter For Robust T-cell And Antibody Responses
App 20180111966 - Steigerwald; Robin ;   et al.
2018-04-26
Methods And Compositions For Enhancing Immune Responses
App 20170340721 - VOLKMANN; Ariane ;   et al.
2017-11-30
Pr13.5 promoter for robust T-cell and antibody responses
Grant 9,828,414 - Steigerwald , et al. November 28, 2
2017-11-28
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine
App 20170326228 - Cheminay; Cedric ;   et al.
2017-11-16
Recombinant Modified Vaccinia Virus Ankara (mva) Filovirus Vaccine
App 20170304427 - Volkmann; Ariane ;   et al.
2017-10-26
Methods And Compositions For Intra-nasal Immunization With Recombinant Mva Encoding Flagellin
App 20170290909 - Lauterbach; Henning ;   et al.
2017-10-12
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection
App 20170290904 - VOLKMANN; Ariane ;   et al.
2017-10-12
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
App 20170266270 - FOY; SUSAN ;   et al.
2017-09-21
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
Grant 9,717,787 - Cheminay , et al. August 1, 2
2017-08-01
Vector Comprising Multiple Homologous Nucleotide Sequences
App 20170211098 - STEIGERWALD; Robin
2017-07-27
Single high dose of MVA induces a protective immune response in neonates and infants
Grant 9,707,291 - Cheminay , et al. July 18, 2
2017-07-18
Agonists And Antagonists Of Toll-like Receptor (tlr) 13
App 20170137820 - Kirschning; Carsten ;   et al.
2017-05-18
Use Of Oil And Water Emulsions For Increasing B Cell Responses With Modified Vaccinia Ankara Virus
App 20170128561 - Cheminay; Cedric ;   et al.
2017-05-11
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of TIM-3
App 20170106065 - FOY; SUSAN ;   et al.
2017-04-20
Recombinant Poxvirus Vector Comprising Tetanus Toxin Fragment C
App 20170081642 - Chaplin; Paul ;   et al.
2017-03-23
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine
App 20170043008 - Cheminay; Cedric ;   et al.
2017-02-16
Agonists and antagonists of toll-like receptor (TLR) 13
Grant 9,556,439 - Kirschning , et al. January 31, 2
2017-01-31
Vector comprising multiple homologous nucleotide sequences
Grant 9,540,660 - Steigerwald January 10, 2
2017-01-10
Compositions And Methods For Inducing An Enhanced Immune Response Using Poxvirus Vectors
App 20160376596 - Hausmann; Jurgen ;   et al.
2016-12-29
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
Grant 9,480,738 - Cheminay , et al. November 1, 2
2016-11-01
Recombinant poxvirus vector comprising tetanus toxin fragment C
Grant 9,463,238 - Chaplin , et al. October 11, 2
2016-10-11
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
App 20160271239 - FOY; SUSAN ;   et al.
2016-09-22
Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
Grant 9,265,823 - Chaplin , et al. February 23, 2
2016-02-23
Single High Dose Of Mva Induces A Protective Immune Response In Neonates And Infants
App 20160030551 - Cheminay; Cedric ;   et al.
2016-02-04
Vector Comprising Multiple Homologous Nucleotide Sequences
App 20160017369 - STEIGERWALD; Robin
2016-01-21
Pr13.5 Promoter For Robust T-cell And Antibody Responses
App 20150299267 - Steigerwald; Robin ;   et al.
2015-10-22
Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements
Grant 9,163,237 - Hausmann , et al. October 20, 2
2015-10-20
Interferon-alpha-producing bone marrow dendritic cells
Grant 9,149,515 - O'Keeffe , et al. October 6, 2
2015-10-06
Recombinant poxvirus expressing homologous genes inserted
Grant 9,109,233 - Howley , et al. August 18, 2
2015-08-18
Purification of vaccinia viruses using hydrophobic interaction chromatography
Grant 9,109,201 - Post Hansen , et al. August 18, 2
2015-08-18
Recombinant Modified Vaccinia Virus Ankara (mva) Respiratory Syncytial Virus (rsv) Vaccine
App 20150209421 - Cheminay; Cedric ;   et al.
2015-07-30
Production of IFN-lambda by conventional dendritic cells
Grant 9,090,897 - Hochrein July 28, 2
2015-07-28
Methods And Compositions For Enhancing Vaccine Immune Responses
App 20150202272 - Lauterbach; Henning ;   et al.
2015-07-23
Poxviral Vectors For Low Antibody Response After A First Priming Immunization
App 20150174238 - Steigerwald; Robin ;   et al.
2015-06-25
Vector comprising multiple homologous nucleotide sequences
Grant 8,999,637 - Steigerwald April 7, 2
2015-04-07
Immediate protection against pathogens via MVA
Grant 8,961,998 - Hochrein , et al. February 24, 2
2015-02-24
Use Of A Modified Poxvirus For The Rapid Induction Of Immunity Against A Poxvirus Or Other Infectious Agents
App 20140341946 - CHAPLIN; Paul ;   et al.
2014-11-20
Promoters For Recombinant Viral Expression
App 20140342403 - STEIGERWALD; Robin ;   et al.
2014-11-20
Modulation of immune responses by the poxviral K4 protein
Grant 8,883,168 - Hausmann , et al. November 11, 2
2014-11-11
Recombinant Poxvirus Vector Comprising Tetanus Toxin Fragment C
App 20140322265 - Chaplin; Paul ;   et al.
2014-10-30
Vaccinia virus mutants containing the major genomic deletions of MVA
Grant 8,859,257 - Hausmann , et al. October 14, 2
2014-10-14
Flavivirus NS1 subunit vaccine
Grant 8,815,501 - Howley , et al. August 26, 2
2014-08-26
Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
Grant 8,808,709 - Chaplin , et al. August 19, 2
2014-08-19
Promoters for recombinant viral expression
Grant 8,772,023 - Steigerwald , et al. July 8, 2
2014-07-08
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Grant 8,741,308 - Howley , et al. June 3, 2
2014-06-03
Replication Deficient Recombinant Viruses Expressing Antigens Regulated By Transcriptional Control Elements Comprising Multiple Elements
App 20140113368 - HAUSMANN; Jurgen ;   et al.
2014-04-24
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
Grant 8,673,318 - Rathe , et al. March 18, 2
2014-03-18
Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements
Grant 8,613,936 - Hausmann , et al. December 24, 2
2013-12-24
Purification Of Vaccinia Viruses Using Hydrophobic Interaction Chromatography
App 20130288339 - POST HANSEN; SARAH ;   et al.
2013-10-31
Intergenic Regions As Insertion Sites In The Genome Of Modified Vaccinia Virus Ankara (mva)
App 20130243813 - HOWLEY; PAUL ;   et al.
2013-09-19
Modulation Of Immune Responses By The Poxviral K4 Protein
App 20130230553 - Hausmann; Jurgen ;   et al.
2013-09-05
Method For Harvesting Expression Products
App 20130183742 - Wehnes; Engelbert ;   et al.
2013-07-18
Purification of vaccinia viruses using hydrophobic interaction chromatography
Grant 8,470,578 - Post Hansen , et al. June 25, 2
2013-06-25
Modified Vaccinia Ankara virus variant and cultivation method
Grant 8,470,598 - Chaplin , et al. June 25, 2
2013-06-25
Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
Grant 8,445,275 - Hochrein , et al. May 21, 2
2013-05-21
Fusion proteins of HIV regulatory/accessory proteins
Grant 8,435,535 - Howley , et al. May 7, 2
2013-05-07
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Grant 8,435,543 - Howley , et al. May 7, 2
2013-05-07
Method For The Cultivation Of Primary Cells And For The Amplification Of Viruses Under Serum Free Conditions
App 20130089913 - RATHE; INGMAR ;   et al.
2013-04-11
Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
Grant 8,415,132 - Djurup , et al. April 9, 2
2013-04-09
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Grant 8,414,900 - Howley , et al. April 9, 2
2013-04-09
Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines
Grant 8,394,385 - Hausmann , et al. March 12, 2
2013-03-12
Fusion proteins of HIV regulatory/accessory proteins
Grant 8,389,275 - Howley , et al. March 5, 2
2013-03-05
Modified vaccinia virus ankara for the vaccination of neonates
Grant 8,372,622 - Suter , et al. February 12, 2
2013-02-12
Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
Grant 8,354,275 - Hochrein , et al. January 15, 2
2013-01-15
Modified Vaccinia Ankara Virus Variant
App 20120328650 - CHAPLIN; PAUL ;   et al.
2012-12-27
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
Grant 8,329,466 - Rathe , et al. December 11, 2
2012-12-11
Vaccinia Virus Mutants Containing The Major Genomic Deletions Of Mva
App 20120308995 - Hausmann; Jurgen ;   et al.
2012-12-06
Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
Grant 8,323,661 - Howley , et al. December 4, 2
2012-12-04
Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)
Grant 8,309,098 - Howley , et al. November 13, 2
2012-11-13
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Grant 8,309,326 - Howley , et al. November 13, 2
2012-11-13
Modified Vaccinia Ankara Virus Variant And Cultivation Method
App 20120276613 - CHAPLIN; PAUL ;   et al.
2012-11-01
Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)
Grant 8,288,125 - Howley , et al. October 16, 2
2012-10-16
Production Of Ifn-lambda By Conventional Dendritic Cells And Uses Thereof
App 20120258082 - Hochrein; Hubertus
2012-10-11
Immediate protection against pathogens via MVA
Grant 8,268,327 - Hochrein , et al. September 18, 2
2012-09-18
Modified Vaccinia Ankara virus variant
Grant 8,268,325 - Chaplin , et al. September 18, 2
2012-09-18
Modified Vaccinia ankara virus variant
Grant 8,268,329 - Chaplin , et al. September 18, 2
2012-09-18
Immediate protection against pathogens via MVA
Grant 8,268,328 - Hochrein , et al. September 18, 2
2012-09-18
Modified Vaccinia Ankara virus variant and cultivation method
Grant 8,236,560 - Chaplin , et al. August 7, 2
2012-08-07
Modified Vaccinia Virus Ankara For The Vaccnation Of Neonates
App 20120183574 - Chaplin; Paul
2012-07-19
Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
Grant 8,211,686 - Djurup , et al. July 3, 2
2012-07-03
Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
Grant 8,198,088 - Howley , et al. June 12, 2
2012-06-12
Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
Grant 8,197,822 - Howley , et al. June 12, 2
2012-06-12
Generation Of A Broad T-cell Response In Humans Against Hiv
App 20120135032 - Chaplin; Paul ;   et al.
2012-05-31
Recombinant poxvirus expressing homologous genes inserted
App 20120135501 - Howley; Paul ;   et al.
2012-05-31
Promoters For Recombinant Viral Expression
App 20120121617 - Steigerwald; Robin ;   et al.
2012-05-17
Purification of vaccinia viruses using hydrophobic interaction chromatography
Grant 8,163,531 - Post Hansen , et al. April 24, 2
2012-04-24
Modified Vaccinia Virus Ankara for the vaccination of neonates
Grant 8,163,293 - Chaplin April 24, 2
2012-04-24
Fusion proteins of HIV regulatory/accessory proteins
Grant 8,147,839 - Howley , et al. April 3, 2
2012-04-03
Monoparamunity inducers based on attenuated rabbit myxomaviruses
Grant 8,142,796 - Mayr , et al. March 27, 2
2012-03-27
Fusion protein of HIV regulatory/accessory proteins
Grant 8,143,054 - Howley , et al. March 27, 2
2012-03-27
Fusion proteins of HIV regulatory/accessory proteins
Grant 8,137,931 - Howley , et al. March 20, 2
2012-03-20
Induction Of Dendritic Cell Development With Macrophage-colony Stimulating Factor (m-csf)
App 20120010597 - HOCHREIN; Hubertus ;   et al.
2012-01-12
Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
Grant 8,053,234 - Hochrein , et al. November 8, 2
2011-11-08
Methods of preparing myxomavirus compositions
Grant 8,039,004 - Mayr , et al. October 18, 2
2011-10-18
Monoparamunity inducers based on attenuated rabbit myxoma viruses
Grant 8,034,356 - Mayr , et al. October 11, 2
2011-10-11
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Grant 8,034,354 - Howley , et al. October 11, 2
2011-10-11
Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
Grant 8,029,800 - Howley , et al. October 4, 2
2011-10-04
Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
Grant 8,021,669 - Howley , et al. September 20, 2
2011-09-20
Method For The Cultivation Of Primary Cells And For The Amplification Of Viruses Under Serum Free Conditions
App 20110217749 - RATHE; INGMAR ;   et al.
2011-09-08
Modified Vaccinia Ankara Virus Variant And Cultivation Method
App 20110217757 - CHAPLIN; PAUL ;   et al.
2011-09-08
Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
Grant 8,012,738 - Djurup , et al. September 6, 2
2011-09-06
Purification of vaccinia viruses using hydrophobic interaction chromatography
Grant 8,003,364 - Post Hansen , et al. August 23, 2
2011-08-23
Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
Grant 8,003,363 - Djurup , et al. August 23, 2
2011-08-23
Modified Vaccinia Ankara Virus Variant
App 20110182933 - CHAPLIN; PAUL ;   et al.
2011-07-28
Modified Vaccinia Ankara Virus Variant
App 20110182932 - CHAPLIN; PAUL ;   et al.
2011-07-28
Modified Vaccinia Virus Ankara For The Vaccination Of Neonates
App 20110159032 - Suter; Mark ;   et al.
2011-06-30
Modified vaccinia ankara virus variant and cultivation method
Grant 7,964,398 - Chaplin , et al. June 21, 2
2011-06-21
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
Grant 7,964,397 - Rathe , et al. June 21, 2
2011-06-21
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Grant 7,964,374 - Howley , et al. June 21, 2
2011-06-21
Modified vaccinia ankara virus variant and cultivation method
Grant 7,964,396 - Chaplin , et al. June 21, 2
2011-06-21
Modified vaccinia ankara virus variant and cultivation method
Grant 7,964,395 - Chaplin , et al. June 21, 2
2011-06-21
Modified Vaccinia Virus Ankara For The Vaccnation Of Neonates
App 20110135683 - Chaplin; Paul
2011-06-09
Modified Vaccinia Ankara virus variant
Grant 7,939,086 - Chaplin , et al. May 10, 2
2011-05-10
Monoparamunity inducers based on attenuated rabbit myxomaviruses
Grant 7,939,085 - Mayr , et al. May 10, 2
2011-05-10
Modified Vaccinia Ankara virus variant
Grant 7,923,017 - Chaplin , et al. April 12, 2
2011-04-12
Modified vaccinia virus ankara for the vaccination of neonates
Grant 7,897,156 - Ackermann , et al. March 1, 2
2011-03-01
Modified vaccinia virus ankara for the vaccination of neonates
Grant 7,892,533 - Suter , et al. February 22, 2
2011-02-22
Promoters For Expression In Modified Vaccinia Virus Ankara
App 20110014242 - LEYRER; SONJA
2011-01-20
Promoters For Expression In Modified Vaccinia Virus Ankara
App 20110008792 - LEYRER; SONJA
2011-01-13
Modified Vaccinia Ankara Virus Variant And Cultivation Method
App 20100279386 - CHAPLIN; PAUL ;   et al.
2010-11-04
Promoters for expression in modified vaccinia virus Ankara
Grant 7,816,508 - Leyrer October 19, 2
2010-10-19
MVA virus vector expressing dengue NS1 protein
Grant 7,759,116 - Howley , et al. July 20, 2
2010-07-20
Induction Of Dendritic Cell Development With Macrophage-colony Stimulating Factor (m-csf)
App 20100167332 - Hochrein; Hubertus ;   et al.
2010-07-01
Modified Vaccinia Ankara Virus Variant
App 20100119545 - Chaplin; Paul ;   et al.
2010-05-13
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
Grant 7,695,939 - Rathe , et al. April 13, 2
2010-04-13
Monoparamunity inducers based on attenuated rabbit myxomaviruses
Grant 7,691,391 - Mayr , et al. April 6, 2
2010-04-06
Modified vaccinia virus ankara for the vaccination of neonates
Grant 7,628,980 - Suter , et al. December 8, 2
2009-12-08
Fusion proteins of non-attenuated HIV regulatory/accessory proteins
Grant 7,569,228 - Howley , et al. August 4, 2
2009-08-04
Modified vaccinia Ankara virus avriant
App 20090169579 - Chaplin; Paul ;   et al.
2009-07-02
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
Grant 7,550,147 - Howley , et al. June 23, 2
2009-06-23
Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
Grant 7,501,127 - Howley , et al. March 10, 2
2009-03-10
Paramunity inducers based on attenuated rabbit myxoma virus
Grant 7,494,799 - Mayr , et al. February 24, 2
2009-02-24
Method For The Cultivation Of Primary Cells And For The Amplification Of Viruses Under Serum Free Conditions
App 20090029459 - RATHE; INGMAR ;   et al.
2009-01-29
Isolated avian cell that expresses Vaccinia virus host range genes
Grant 7,473,536 - Howley , et al. January 6, 2
2009-01-06
Modified Vaccinia Ankara virus variant
Grant 7,459,270 - Chaplin , et al. December 2, 2
2008-12-02
Modified Vaccinia Ankara virus variant and cultivation method
Grant 7,445,924 - Chaplin , et al. November 4, 2
2008-11-04
Modified Vaccinia Ankara virus variant
Grant 7,384,644 - Chaplin , et al. June 10, 2
2008-06-10
Modified vaccinia Ankara virus variant
App 20080089907 - Chaplin; Paul ;   et al.
2008-04-17
Recombinant poxvirus expressing homologous genes inserted into the foxviral genome
Grant 7,338,662 - Howley , et al. March 4, 2
2008-03-04
Modified Vaccinia Ankara virus variant
Grant 7,335,364 - Chaplin , et al. February 26, 2
2008-02-26
Recombinant poxvirus comprising at least two compox ATI promoters
Grant 7,300,658 - Howley , et al. November 27, 2
2007-11-27
Modified vaccinia ankara virus variant
Grant 7,189,536 - Chaplin , et al. March 13, 2
2007-03-13
Modified vaccinia ankara virus variant
App 20060280758 - Chaplin; Paul ;   et al.
2006-12-14
Fusion proteins of HIV regulatory/accessory proteins
App 20060257974 - Howley; Paul ;   et al.
2006-11-16
Modified vaccinia virus ankara for the vaccination of neonates
Grant 7,097,842 - Suter , et al. August 29, 2
2006-08-29
Poxvirus containing formulations and process for preparing stable poxvirus containing compositions
Grant 7,094,412 - Howley , et al. August 22, 2
2006-08-22
Injection device and method for injecting capsules
Grant 7,083,607 - Lohr , et al. August 1, 2
2006-08-01
Modified Vaccinia virus Ankara for the vaccination of neonates
App 20060127984 - Ackermann; Mathias ;   et al.
2006-06-15
Method for the recovery and purification of poxviruses from infected cells
Grant 7,056,723 - Heller , et al. June 6, 2
2006-06-06
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
App 20050214324 - Rathe, Ingmar ;   et al.
2005-09-29
Method for virus propagation
Grant 6,924,137 - Howley , et al. August 2, 2
2005-08-02
Modified Vaccinia Ankara virus variant
Grant 6,913,752 - Chaplin , et al. July 5, 2
2005-07-05
Encapsulated cells producing cytochrome P450
Grant 6,893,634 - Gunzburg , et al. May 17, 2
2005-05-17
Encapsulated cells producing viral particles
Grant 6,776,985 - Saller , et al. August 17, 2
2004-08-17
Modified vaccinia ankara virus variant
Grant 6,761,893 - Chaplin , et al. July 13, 2
2004-07-13
Altered strain of the modified vaccinia virus ankara (MVA)
Grant 6,682,743 - Mayr January 27, 2
2004-01-27
Modified Vaccinia Virus Ankara for the vaccination of neonates
App 20030224018 - Ackermann, Mathias ;   et al.
2003-12-04
Quantification by inhibition of amplification
App 20030129637 - Steinborn, Ralf ;   et al.
2003-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed